APA (7th ed.) Citation

S, M., L, C., E, C., A, D., C, J., D, S., . . . M, P. (2026). Developing low-carbon salbutamol MDI: Assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a. BMJ open respiratory research, 13(1), . https://doi.org/10.1136/bmjresp-2025-004036

Chicago Style (17th ed.) Citation

S, Moreira, et al. "Developing Low-carbon Salbutamol MDI: Assessment of Relative Bioavailability and Pharmacodynamic Relative Potency of Salbutamol MDI with Propellant HFA-152a." BMJ Open Respiratory Research 13, no. 1 (2026). https://doi.org/10.1136/bmjresp-2025-004036.

MLA (9th ed.) Citation

S, Moreira, et al. "Developing Low-carbon Salbutamol MDI: Assessment of Relative Bioavailability and Pharmacodynamic Relative Potency of Salbutamol MDI with Propellant HFA-152a." BMJ Open Respiratory Research, vol. 13, no. 1, 2026, https://doi.org/10.1136/bmjresp-2025-004036.